BMC

17/08/2025

An article published in BMC Biology presents iVAE: an interpretable representation learning framework that enhances clustering performance for single-cell data.

Link in the comments.

16/08/2025

A study in BMC Medicine provides the first experimental evidence in healthy individuals that positive labeling of a treatment can reduce sickness symptoms and enhance the efficacy of ibuprofen in alleviating psychological distress during acute systemic inflammation.

Background Systemic inflammation triggers a wide range of sickness symptoms, including bodily discomfort and affective symptoms, which are relevant to numerous health conditions. While extensive research in the placebo field demonstrates that positive expectations can improve symptoms, it remains un...

16/08/2025

A study published in the Journal of Health, Population and Nutrition finds magnesium depletion score as a promising biomarker for mortality risk stratification in patients with hyperlipidemia.

Background Magnesium, an essential dietary trace element, plays a crucial role in numerous physiological processes, and its deficiency has been associated with the development of hyperlipidemia. However, its potential to predict long-term outcomes and inform risk stratification in hyperlipidemic pat...

15/08/2025

A study published in Gut Pathogens discusses the mechanisms underlying antibiotic-induced bone loss and underscores the significant role of the pathogenic bacterium K. variicola in the development of osteoporosis.

Link in the comments.

15/08/2025

A study in BMC Medicine introduces a long-term well-being composite metric that integrates comorbidity, discrimination, and health-related quality of life as critical domains for monitoring and improving the health of people living with HIV in Spain.

Background Achieving long-term well-being for people living with HIV (PLHIV) requires moving beyond viral suppression to address health-related quality of life (HRQoL), encompassing physical, mental, and social dimensions. This study aimed to develop a composite metric to monitor and improve the lon...

15/08/2025

A study published in BMC Cancer proposes circulating tumor biomarker eHsp70 levels before any treatment as a predictive biomarker for the presence of lymph node metastases and early therapy failure in patients with thoracic malignancies.

Background Heat shock protein 70 (Hsp70) which is frequently overexpressed in many different cancer types is also present on the plasma membrane of tumor but not normal cells. The intensity of membrane-expressed Hsp70 (mHsp70) is associated with disease progression and treatment resistance. It has a...

14/08/2025

A Case Report in the Journal of Medical Case Reports presents a rare case of a 40-year-old Black Ethiopian pregnant woman with Wolf–Parkinson–White syndrome, which was unmasked after successful cardioversion of unstable ventricular tachycardia.

Link in the comments.

14/08/2025

A systematic review and meta-analysis published in BMC Neurology finds that remote electrical neuromodulation reduces and relieves migraine pain at both 2- and 24-hours post-attack while also improving functional ability and quality of life.

Migraine is a disabling disorder characterized by recurrent severe headache attacks. Non-invasive neuromodulation can be employed in the prevention and/or acute treatment of migraine. Remote electrical neuromodulation (REN), a type of non-invasive neuromodulation, is an effective and safe at-home tr...

14/08/2025

Sesame oil consumption significantly improves glycemic control biomarkers in women with metabolic dysfunction-associated steatotic liver disease, suggesting potential metabolic benefits beyond weight loss, finds a study published in BMC Nutrition.

Link in the comments.

13/08/2025

The International Journal for Health Geographics is calling for papers to its Collection on "The Generative Revolution: Generative AI in Health Geomatics", which is guest edited by Maged N. Kamel Boulos & Lan Mu.
Read more here: https://bit.ly/3UTqu8d

13/08/2025

A study published in BMC Cancer finds that immune checkpoint inhibitor-associated myocarditis and pericarditis significantly increase the mortality risk among cancer patients, particularly with the use of nivolumab and pembrolizumab.

Link in the comments.